Nam Q. Bui, MD

Division of Oncology, Department of Medicine, Stanford University
Stanford, California, United States

Disclosure information not submitted.

Presentation(s):

• Paper 87 - CELLSARCTX: A SINGLE-CELL TRANSCRIPTOMICS ATLAS OF ADOPTIVE CELLULAR THERAPY TARGETS IN SOFT TISSUE SARCOMAS

  Saturday, November 16, 2024
  10:30 AM – 12:00 PM PST

• Paper 102 - EFFICACY OF NIROGACESTAT IN PATIENTS WITH DESMOID TUMORS AND POOR PROGNOSTIC FACTORS: PATIENT-REPORTED OUTCOMES, PROGRESSION-FREE SURVIVAL, AND OBJECTIVE RESPONSE RATE IN THE PHASE 3 DEFI TRIAL

  Saturday, November 16, 2024
  3:30 PM – 4:30 PM PST

• Paper 103 - NIROGACESTAT TREATMENT IN ADULT PATIENTS WITH DESMOID TUMORS: LONG-TERM EFFICACY AND SAFETY FROM THE PHASE 3 DEFI TRIAL

  Saturday, November 16, 2024
  3:30 PM – 4:30 PM PST